Prospera Financial Services’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,451
| Closed | -$212K | – | 1160 |
|
|
2024
Q2 | $212K | Sell |
4,451
-166
| -4% | -$7.91K | 0.01% | 1053 |
|
|
2024
Q1 | $200K | Sell |
4,617
-81
| -2% | -$3.51K | 0.01% | 1043 |
|
|
2023
Q4 | $238K | Sell |
4,698
-55
| -1% | -$2.78K | 0.01% | 933 |
|
|
2023
Q3 | $216K | Buy |
+4,753
| New | +$216K | 0.01% | 927 |
|
|
2022
Q4 | – | Sell |
-5,095
| Closed | -$226K | – | 929 |
|
|
2022
Q3 | $226K | Sell |
5,095
-26,189
| -84% | -$1.16M | 0.01% | 741 |
|
|
2022
Q2 | $1.16M | Buy |
31,284
+26,644
| +574% | +$986K | 0.06% | 336 |
|
|
2022
Q1 | $172K | Buy |
+4,640
| New | +$172K | 0.01% | 927 |
|
|
2020
Q4 | – | Sell |
-177
| Closed | -$8K | – | 1104 |
|
|
2020
Q3 | $8K | Sell |
177
-4,924
| -97% | -$223K | ﹤0.01% | 1169 |
|
|
2020
Q2 | $301K | Sell |
5,101
-2,749
| -35% | -$162K | 0.03% | 440 |
|
|
2020
Q1 | $371K | Sell |
7,850
-1,244
| -14% | -$58.8K | 0.04% | 366 |
|
|
2019
Q4 | $549K | Buy |
9,094
+1,134
| +14% | +$68.5K | 0.04% | 365 |
|
|
2019
Q3 | $477K | Buy |
+7,960
| New | +$477K | 0.05% | 318 |
|